# Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy

> **NCT02291094** · PHASE4 · COMPLETED · sponsor: **Hospital de Base** · enrollment: 60 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT02291094
- **Lead sponsor:** Hospital de Base
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291094, "Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT02291094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*